Compare FMC Corp (FMC) vs Zscaler Inc (ZS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Zscaler Inc — how do they compare? FMC Corp trades at $11.41 (market cap $1.36B), while Zscaler Inc trades at $147.28 (market cap $23.96B). The key difference: Zscaler Inc is far larger — about 17.6× FMC Corp's market cap, and FMC Corp pays a 2.95% dividend while Zscaler Inc pays none. Which is the better fit depends on your goals.
| FMC | ZS | |
|---|---|---|
Market Cap | $1.36B | $23.96B |
Sector | Basic Materials | Technology |
52-Week High | $43.90 | $336.27 |
52-Week Low | $10.72 | $118.05 |
Enterprise Value | $5.50B | $22.29B |
Dividend Yield | 2.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Zscaler (ZS) trades at $146.75, down 3.51% on the day, with a bullish technical outlook supported by moving averages and key support at $145. The company shows strong revenue growth, reaching $2.67B in 2025, but remains unprofitable with a net margin of -2.44%. Recent quarters have consistently beaten EPS expectations, and analyst sentiment is overwhelmingly positive with 79% buy ratings.
ZS offers growth potential in cybersecurity with Zero Trust adoption and AI integration, but faces risks from profitability challenges, rising infrastructure costs, and legal investigations. The consensus price target of $192.64 implies significant upside, though investors must weigh strong demand against margin pressures and competitive threats.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Zscaler Inc
Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →
